| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.5B | $3.7B | $5.0B | $1.3B | $0.9B | $0.9B | $1.1B | $1.1B |
| Cost of Revenue | $3.2B | $3.5B | $4.7B | $4.1B | $2.7B | $3.4B | $4.1B | $3.8B |
| Gross Profit | $0.3B | $0.1B | $0.3B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.3B | $0.3B | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B |
| Operating Income | $-0.0B | $-0.5B | $-0.4B | $0.0B | $0.1B | $-0.0B | $0.0B | $0.2B |
| Net Income | $-0.3B | $-0.7B | $-0.4B | $0.1B | $0.1B | $0.0B | $-0.0B | $0.1B |
| EPS (Basic) | $-9.86 | $-19.88 | $-11.99 | $3.20 | $1.74 | $0.14 | $-0.02 | $2.69 |
| EPS (Diluted) | $-9.86 | $-19.88 | $-11.99 | $3.14 | $1.71 | $0.14 | $-0.02 | $2.63 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.6B | $3.0B | $3.8B | $4.7B | $2.8B | $2.8B | $2.7B | $2.8B |
| Current Assets | $1.0B | $1.2B | $1.4B | $2.0B | $1.5B | $1.5B | $1.6B | $1.6B |
| Cash & Equivalents | $0.2B | $0.3B | $0.2B | $0.6B | $0.6B | $0.5B | $0.5B | $0.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.7B | $0.7B | $0.7B | $0.9B | $0.5B | $0.5B | $0.5B | $0.6B |
| Stockholders' Equity | $-0.6B | $-0.3B | $0.4B | $1.0B | $0.6B | $0.7B | $0.8B | $0.7B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.0B | $0.1B | $0.0B | $0.5B | $0.3B | $0.3B | $0.4B | $0.4B |
| Investing Cash Flow | $-0.1B | $-0.0B | $-0.2B | $-1.5B | $-0.0B | $-0.1B | $-0.1B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.0B | $-0.1B | $-0.2B | $1.1B | $-0.1B | $-0.2B | $-0.2B | $-0.3B |